Navigation Links
For Second Year in a Row, RIVA Named Top IV Robot in Study Ranking Pharmacy Automation
Date:8/7/2014

WINNIPEG, Manitoba, Aug. 7, 2014 /PRNewswire/ -- For the second consecutive year, RIVA, the fully automated IV compounding system developed by Intelligent Hospital Systems (IH Systems), has been recognized as category leader in "Pharmacy automation: IV robots" by independent healthcare research firm KLAS. The top ranking was announced in its recent "2014 Best in KLAS: Medical Equipment & Infrastructure" report. RIVA's overall score of 81.3 is the highest for IV robots (one component of the RIVA system is a robotic arm) used in pharmacy automation that were evaluated in the report.

"Ongoing pharmacy product recalls and the passage of legislation in the U.S. to better regulate pharmacies show automation is an increasingly necessary solution for safe and efficient pharmacy production," said Dr. Niels Erik Hansen, president and CEO of IH Systems. "RIVA continues to be recognized by pharmacists not only for enhancing medication and patient safety, but also for increasing efficiency and reducing costs."

To compile its annual ranking of medical equipment, KLAS collects data from thousands of healthcare providers and administrators across the U.S. and Canada through surveys and in-depth interviews. The 2014 Best in KLAS report ranks pharmacy and medical products in 21 different market segments.

This is the third time in three years that RIVA has been recognized in a KLAS report. An earlier study of pharmacy automation, "U.S. IV Automation: Robots and Workflow Solutions in 2012," gave RIVA high marks for having needed functionality, being ready for widespread industry use and customers that would buy it again.

In the 2013 Best in KLAS report, RIVA was recognized as category leader for IV robots in pharmacy automation, a ranking that RIVA repeated in this year's Best in KLAS study. Data in the 2013 report found 95 percent of RIVA customers surveyed by KLAS indicated they would buy the RIVA system again.

RIVA is engineered with multiple safety technologies and prepares IV medications in an aseptic ISO Class 5 environment with laminar airflow. RIVA units have been installed at 35 sites worldwide and have cumulatively produced millions of IV doses safely and accurately. Installed units also have performed hundreds of thousands of routine contamination tests with zero failures. Customer feedback indicates users continue to rate RIVA's safety technology and IH Systems' customer service among the best in the industry. Several customers have purchased multiple RIVA systems to fulfill a greater portion of their IV medication production.

KLAS report citations:
"2014 Best in KLAS: Medical Equipment & Infrastructure," July 2014. © 2014 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com.
"2013 Best in KLAS Awards: Medical Equipment & Infrastructure," June 2013. © 2013 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com.
"U.S. IV Automation: Robots and Workflow Solutions in 2012," October, 2012. © 2012 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com.

About Intelligent Hospital Systems

Intelligent Hospital Systems (IH Systems) is a medical device company focused on the design and development of automated solutions for the hospital environment. Based in Winnipeg, Manitoba, IH Systems manufactures RIVA, a fully-automated IV manufacturing system that prepares medications for syringes and IV bags in an aseptic environment. Using RIVA, hospitals enhance patient safety, lower the cost-per-dose of medications, reduce their vulnerability to medication shortages and cut waste. For more information, visit www.intelligenthospitals.com.

About KLAS

KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment and infrastructure systems to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving supplier performance. KLAS was founded in 1996, and their staff and advisory board average 25 years of healthcare information technology experience. Follow KLAS on Twitter at www.twitter.com/KLASresearch.

Logo - http://photos.prnewswire.com/prnh/20140807/134395


'/>"/>
SOURCE Intelligent Hospital Systems
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Ardelyx Reports Second Quarter 2014 Financial Results
2. KaloBios Provides Clinical Update and Reports Second Quarter Financial Results
3. Celsion Corporation Reports Second Quarter 2014 Financial Results
4. NxStage Reports Record Second Quarter 2014 Financial Results And Increases Full-Year Revenue Guidance
5. Orexigen Therapeutics Reports Corporate and Financial Results for the Second Quarter Ended June 30, 2014
6. EnteroMedics Reports Second Quarter 2014 Financial Results
7. Vanda Pharmaceuticals Reports Second Quarter 2014 Results
8. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2014 Second Quarter Financial Results
9. AcelRx Pharmaceuticals to Hold Second Quarter Financial Results Conference Call and Webcast on Monday, August 11th, 2014.
10. PTC Therapeutics Reports Second Quarter Financial Results and Provides Corporate Update
11. Mylan Reports Second Quarter 2014 Adjusted Diluted EPS of $0.69, In Line With Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Kalifornien, 12. Februar 2016  Sequent ... der Aufnahme von Patienten für eine Studie zur ... Aneurysmen („WEB") speziell für die Behandlung von rupturierten ... , MD, Leiter der Neuroradiologie an der Universitätsklinik ... und Hauptprüfarzt der CLARYS-Studie hat den ersten Patienten ...
(Date:2/12/2016)... , Feb. 12, 2016  Eli Lilly and Company ... Court decided the Alimta® (pemetrexed disodium) vitamin regimen patent would ... the UK, France , Italy ... to dilute the product only with dextrose solution.  ... 2015, the UK Court of Appeal held that Lilly,s patent ...
(Date:2/12/2016)... BUDAPEST , Ungarn, February 12, 2016 ... ein Medizintechnikunternehmen, das sich auf den ungedeckten ... gab heute positive Ergebnisse seines klinischen Forschungsprogramms ... und Asthma-Patienten beschäftigt, ergab Verbesserungen ihrer respiratorischen ... Indiso ltd , ein Medizintechnikunternehmen, das ...
Breaking Medicine Technology:
(Date:2/13/2016)... ... ... DDi , a Makro company, makes it to ... in eClinical Solutions. DDi has built its solution competency with a unique blend ... DDi provides smarter technology for Clinical Development, Regulatory and Enterprise domains by providing ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... over 250 members of South Florida’s philanthropic community at its 10th anniversary Fashion ...
(Date:2/12/2016)... ... 2016 , ... Coco Libre, the maker of coconut water beverages with a ... Lounge Event. Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut ... invitation-only gifting suite, held this year at the W Hollywood Hotel, has become a ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fisher House Foundation Chairman ... John J. Lee, Nevada Military Support Alliance president Scott Bensing, and Peggy Kearns Director, ... VA Southern Nevada Healthcare System. This will be the first Fisher House in ...
(Date:2/12/2016)... ... February 12, 2016 , ... Young ... area, celebrates the beginning of the latest charity campaign in their community enrichment ... art. Donations to this worthy cause are currently being accepted at: http://artexpressioninc.org/ ...
Breaking Medicine News(10 mins):